Top Markets
Coin of the day
Accustem Sciences Inc. Accustem Sciences Inc.

Accustem Sciences Inc.

ACUT
Rank in Stocks #36602
AccuStem Sciences, Inc. operates as a life science firm committed to improving... AccuStem Sciences, Inc. operates as a life science firm committed to improving the outlook for individuals battling cancer. Its primary innovation is the StemPrintER technology, an advanced multi-gene prognostic assay designed to predict the likelihood of recurrence for patients with Endocrine receptor-positive /HER2- breast cancer. The company also offers Spare, a related diagnostic tool that expands upon StemPrintER by incorporating two additional clinical markers. AccuStem Sciences, Inc. is based in New York, New York.
Share Price
$0.156
Last synced: 2026-08-13
Market Cap
$2.51M
Change (1 day)
2.97%
Change (1 year)
-91.28%
Country
US
Trade Accustem Sciences Inc. (ACUT)

Category

EPS for Accustem Sciences Inc. (ACUT)
EPS as of 2026 TTM: 0
According to Accustem Sciences Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Accustem Sciences Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE